This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. | MicrobiomeTrials
← Back to trials NCT05776927
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-08-04Est. Completion: 2028-12-30
Enrollment target: 188 participantsLocations Novartis Investigative Site, Strasbourg, France Novartis Investigative Site, Szeged, Hungary Novartis Investigative Site, Tarnów, Poland, Poland Novartis Investigative Site, Bialystok, Poland Novartis Investigative Site, Krakow, Poland Novartis Investigative Site, Lublin, Poland Novartis Investigative Site, Piaseczno, Poland Novartis Investigative Site, Torun, Poland Novartis Investigative Site, Bucharest, Romania Novartis Investigative Site, Bratislava, Mestska Cast Ruzinov, Slovakia Novartis Investigative Site, East London, Eastern Cape, South Africa Novartis Investigative Site, Germiston, Gauteng, South Africa Novartis Investigative Site, Krugersdorp, Gauteng, South Africa Novartis Investigative Site, Lenasia, Gauteng, South Africa Novartis Investigative Site, Paarl, Western Cape, South Africa Novartis Investigative Site, Santiago Compostela, A Coruna, Spain Novartis Investigative Site, Sabadell, Barcelona, Spain Other microbiome trials you might be interested in Type 1 Diabetes Mellitus Obesity Asthma
A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 di…
Ghent, Belgium Est. completion Dec 2026
Asthma
The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate …
Birmingham, United States Est. completion Oct 31, 2026
Novartis Investigative Site, Seville, Spain
Novartis Investigative Site, Kaohsiung City, Taiwan Contact Novartis Pharmaceuticals
Completed
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)
This observational study aims to evaluate the long-term effectiveness and safety of mepolizumab 300 mg/4 weeks in adults…
Florence, Italy Completed Mar 31, 2026